Central Nervous System II (Non-Viral Meningitis and Encephalitis) (1 Challenge) EQA/PT Scheme

The central nervous system II (non-viral meningitis and encephalitis) EQA scheme will focus on the molecular detection and determination of various Listeria spp, Neisseria meningitidis, Streptococcus pneumoniae, Streptococcus agalactiae , Escherichia coli K1, Cryptococcus spp. or Haemophilus influenzae strains. The panel is designed to represent various clinical scenarios.

Total Number of Challenges: 1
Number of Panel Members: 10
Distribution / Testing Period: Q4
Sample NA Target Source Cultured material and/or Clinical material
Matrix Panel Format Synthetic CSF and/or Transport Medium
Panel Member Target Range Covering clinical range
Panel Member Sample Volume 1.0 ml
Panel Sample Pre-treatment Requirement Ready for analysis. Treat as clinical samples and analyse accordingly.
Panel Analysis Type Qualitative. Quantitative for information purposes only
Panel Testing Evaluated by various molecular methodologies
Storage / Shipment Conditions <-20°C / Frozen on Dry-ice
Accreditation / Regulatory Status Accredited to ISO 17043

$1,277.01